Clinical Trials Browser

NETWORK × Pluvicto × 90 days × Clear all

NCT06783348 2026-06-04

RENALUT

Phase 2 Recruiting

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

NCT04663997 2026-03-27

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms